Adora Ndu

Adora Ndu, PharmD, JD, currently serves as the Chief Regulatory Affairs Officer at BridgeBio and the Interim Chief Legal Officer at Acadia Pharmaceuticals Inc., while also holding positions on the Board of Directors for both Acadia Pharmaceuticals and DBV Technologies. With extensive experience in regulatory affairs and legal roles, Adora Ndu has previously worked in various leadership positions at BioMarin Pharmaceutical Inc. and the FDA. Adora Ndu's academic credentials include a Doctor of Pharmacy from Howard University, a Doctor of Law from the University of Maryland, and additional business education from Harvard Business School and Stanford University Graduate School of Business. Adora Ndu also contributes to education as an adjunct faculty member at The Johns Hopkins University.